Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis
2
조회
0
다운로드
9
인용
0
참고문헌
초록
Background/Aims: Liver biopsy is a standard method for diagnosis of liver cirrhosis in patients with chronic hepatitis. Because liver biopsy is an invasive method, non-invasive methods have been used for diagnosis of compensated liver cirrhosis in patients with chronic hepatitis. The current study was designed to evaluate the usefulness of ultrasonography and routine blood tests for diagnosis of compensated liver cirrhosis in patients with chronic viral hepatitis. Methods: Two hundred three patients with chronic viral hepatitis who underwent liver biopsy were included in this study and ultrasonography and routine blood tests were analyzed retrospectively. Ultrasonographic findings, including surface nodularity, parenchyma echogenecity, and spleen size, were evaluated. The diagnostic accuracy of ultrasonography and routine blood tests were examined. Results: Discriminant analysis with forward stepwise selection of variables showed that liver surface nodularity, platelet count, and albumin level were independently associated with compensated liver cirrhosis (p<0.05). Cross-tabulation revealed that the following 4 variables had >95% specificity: platelet count <100,000 /uL; albumin level <3.5 g/dL; INR >1.3; and surface nodularity. If at least one of the four variables exists in a patient with chronic viral hepatitis, we can predict liver cirrhosis with 90% specificity and 61% sensitivity. Conclusions: These results suggest that four variables (platelet count <100,000 /uL, albumin level <3.5 g/dL, INR >1.3, and surface nodularity) can be used for identification of liver cirrhosis in patients with chronic viral hepatitis with high specificity.
Abstract
Background/Aims: Liver biopsy is a standard method for diagnosis of liver cirrhosis in patients with chronic hepatitis. Because liver biopsy is an invasive method, non-invasive methods have been used for diagnosis of compensated liver cirrhosis in patients with chronic hepatitis. The current study was designed to evaluate the usefulness of ultrasonography and routine blood tests for diagnosis of compensated liver cirrhosis in patients with chronic viral hepatitis. Methods: Two hundred three patients with chronic viral hepatitis who underwent liver biopsy were included in this study and ultrasonography and routine blood tests were analyzed retrospectively. Ultrasonographic findings, including surface nodularity, parenchyma echogenecity, and spleen size, were evaluated. The diagnostic accuracy of ultrasonography and routine blood tests were examined. Results: Discriminant analysis with forward stepwise selection of variables showed that liver surface nodularity, platelet count, and albumin level were independently associated with compensated liver cirrhosis (p<0.05). Cross-tabulation revealed that the following 4 variables had >95% specificity: platelet count <100,000 /uL; albumin level <3.5 g/dL; INR >1.3; and surface nodularity. If at least one of the four variables exists in a patient with chronic viral hepatitis, we can predict liver cirrhosis with 90% specificity and 61% sensitivity. Conclusions: These results suggest that four variables (platelet count <100,000 /uL, albumin level <3.5 g/dL, INR >1.3, and surface nodularity) can be used for identification of liver cirrhosis in patients with chronic viral hepatitis with high specificity.
참고문헌 (29)
- Anthony PP, "The morphology of cirrhosis: definition, nomenclature, and classification", Bull World Health Organ, 55, pp.521~540 (1977)
- Maynard JE, "Hepatitis B: global importance and need for control", Vaccine, (8), pp.S18~20 (1990)
- Alter MJ, "Epidemiology of hepatitis C", Hepatology, 26(1), pp.62S~65S (1997)
- Sorrell MF, "National institutes of health consensus development conference statement: management of hepatitis B", Hepatology, 49, pp.S4~S12 (2009)
- 백승운, "C형간염의 치료 목표, 대상 및 치료", 대한소화기학회지, 51(6), pp.368~371 (2008), 대한소화기학회
- Bravo AA, "Liver biopsy", N Engl J Med, 344, pp.495~500 (2001)
- Piccinino F, "Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies", J Hepatol, 2, pp.165~173 (1986)
- Abdi W, "Sampling variability on percutaneous liver biopsy", Arch Intern Med, 139, pp.667~669 (1979)
- Bedossa P, "Sampling variability of liver fibrosis in chronic hepatitis C", Hepatology, 38, pp.1449~1457 (2003)
- Laharie D, "Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate", Aliment Pharmacol Ther, 23, pp.1621~1628 (2006)
- Forns X, "Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model", Hepatology, 36, pp.986~992 (2002)
- Chen YP, "Model consisting of ultrasonographic and simple blood indexes accurately identify compensated hepatitis B cirrhosis", J Gastroenterol Hepatol, 23, pp.1228~1234 (2008)
- Park YN, "Histological Grading and Staging of Chronic Hepatitis Standardized Guideline Proposed by the Korean Study Group for the Pathology of Digestive Diseases", Korean J Pathol, 33, pp.337~346 (1999)
- Poynard T, "Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups", Lancet, 349, pp.825~832 (1997)
- Fontaine H, "Guidelines for the diagnosis of uncomplicated cirrhosis", Gastroenterol Clin Biol, 31, pp.504~509 (2007)
- Sebastiani G, "Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms", World J Gastroenterol, 15, pp.2190~2203 (2009)
- Kudo M, "Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study", Intervirology, 51(1), pp.17~26 (2008)
- Gaiani S, "D'Errico A, et al. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy", J Hepatol, 27, pp.979~985 (1997)
- Di Lelio A, "Cirrhosis: diagnosis with sonographic study of the liver surface", Radiology, 172, pp.389~392 (1989)
- Colli A, "Severe liver fibrosis or cirrhosis: accuracy of US for detection-analysis of 300 cases", Radiology, 227, pp.89~94 (2003)
- Shen L, "Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis", World J Gastroenterol, 12, pp.1292~1295 (2006)
- Ong TZ, "Ultrasonography is not reliable in diagnosing liver cirrhosis in clinical practice. Singapore Med J 2003;44:293-295", Singapore Med J, 44, pp.293~295 (2003)
- Guéchot J, "Serum hyaluronan as a marker of liver fibrosis", J Hepatol, 22, pp.103~106 (1995)
- Mehta P, "Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C", Am J Gastroenterol, 103, pp.928~936 (2008)
- Murawaki Y, "Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C", J Gastroenterol, 36, pp.399~406 (2001)
- Lackner C, "Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C", Hepatology, 41, pp.1376~1382 (2005)
- Wai CT, "A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C", Hepatology, 38, pp.518~526 (2003)
- Kim BK, "Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients", Liver Int, 30, pp.546~553 (2010)
- Llovet JM, "Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation", Hepatology, 30, pp.1434~1440 (1999)